2025-08-25 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the data you provided, presented as a concise report in English:

## Teladoc Health Inc (TDOC) Stock Analysis

**Company Overview:** Teladoc Health Inc is a telehealth company that provides virtual healthcare services.

**1. Performance vs. S&P 500 (VOO):**

*   **TDOC Cumulative Return:** -64.22%
*   **VOO Cumulative Return:** 38.83%
*   **Absolute Deviation:** -166.7
*   **Relative Deviation:** 0.1

**Analysis:** TDOC has significantly underperformed the S&P 500. The large negative absolute deviation highlights this substantial difference in returns. The relative deviation suggests the current underperformance is near the lower end of its historical range relative to the S&P 500.

**Alpha/Beta Analysis:**

| Year       | CAGR     | MDD   | Alpha    | Beta | Cap(B) |
|------------|----------|-------|----------|------|--------|
| 2015-2017  | 76.0%    | 60.6% | 76.0%    | 1.0  | 6.2    |
| 2016-2018  | 128.0%   | 59.3% | 128.0%   | 1.0  | 8.8    |
| 2017-2019  | 176.0%   | 59.3% | 176.0%   | 1.0  | 14.8   |
| 2018-2020  | 237.0%   | 64.0% | 237.0%   | 1.0  | 35.3   |
| 2019-2021  | -83.0%   | 64.0% | -84.0%   | -0.0 | 16.2   |
| 2020-2022  | -295.0%  | 81.3% | -284.0%  | -0.0 | 4.2    |
| 2021-2023  | -488.0%  | 81.3% | -498.0%  | 0.0  | 3.8    |
| 2022-2024  | -111.0%  | 81.3% | -141.0%  | 0.0  | 1.6    |
| 2023-2025  | -35.0%   | 75.5% | -80.0%   | 0.0  | 1.4    |

**Analysis:** The table shows a dramatic shift in performance.  From high growth and positive alpha in earlier periods, TDOC has experienced significant negative returns, high MDD (Max Drawdown), and negative alpha in recent years. Beta is close to zero, indicating very low correlation with the market. This suggests the stock's performance is driven by company-specific factors rather than overall market trends.

**2. Recent Stock Price Movement:**

*   **Current Price:** $7.68
*   **Previous Close:** $7.19
*   **Change:** 6.82%
*   **5-Day Moving Average:** 7.384
*   **20-Day Moving Average:** 7.247
*   **60-Day Moving Average:** 7.6107

**Analysis:**  The recent price surge (6.82% change) is a positive sign. The price is currently above the 5-day and 20-day moving averages, suggesting short-term upward momentum. The price is hovering around the 60-day moving average, indicating a potential test of longer-term resistance.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.3377 (Low Risk)
*   **RSI:** 66.82 (Approaching Overbought)
*   **PPO:** 0.8084
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **20-Day Relative Deviation Change:** 0.1 (Positive, indicating short-term increase)
*   **Expected Return:** -10107.4%

**Analysis:** The MRI suggests a low-risk market environment, but it's important to note that this is a general market indicator and may not be specific to TDOC. The RSI is approaching overbought territory, which could signal a potential pullback. The Hybrid Signal suggests buying 80% with caution given the MRI. The positive change in relative deviation suggests some recent improvement, but the extremely negative expected return is a major red flag.

**4. Recent News & Significant Events:**

*   **[2025-08-21]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-24]:** Analysts discussing performance and outlook.
*   **[2025-08-25]:** Notable volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-08-23]:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news snippets indicate recent volatility and significant developments impacting TDOC. Investors should closely monitor news and company announcements to understand the drivers behind these events.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-07-30 | -0.19 | 0.63 B$   |
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2025-07-30 | -4.92 | 0.64 B$   |

**Analysis:** TDOC has consistently reported negative EPS. While revenue has been relatively stable, the significant EPS loss in 2024-08-01 is a concern.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $0.63B     | 69.85%        |
| 2025-03-31 | $0.63B     | 68.73%        |
| 2024-12-31 | $0.64B     | 70.50%        |
| 2024-09-30 | $0.64B     | 71.94%        |
| 2024-06-30 | $0.64B     | 70.73%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE       |
|------------|------------|-----------|
| 2025-06-30 | $1.42B     | -2.30%    |
| 2025-03-31 | $1.43B     | -6.52%    |
| 2024-12-31 | $1.49B     | -3.25%    |
| 2024-09-30 | $1.51B     | -2.21%    |
| 2024-06-30 | $1.50B     | -55.77%   |

**Analysis:** Revenue has been relatively stable. While profit margins are high, negative ROE values indicate that the company is not generating profits from its equity. The decreasing equity balance is also a negative sign.

**7. Overall Analysis:**

TDOC has experienced significant underperformance compared to the S&P 500. Recent news suggests volatility and major developments are impacting the stock. While there has been a recent price surge, technical indicators like RSI are approaching overbought territory, suggesting a potential pullback. The company is consistently reporting negative EPS and negative ROE. The dramatically negative long-term expected return is a significant cause for concern.

**In summary, while there might be short-term trading opportunities based on recent price movement, the overall outlook for TDOC appears negative based on the provided data. Investors should exercise extreme caution and conduct thorough due diligence before investing.**
